FindTrial
Sign In

Evaluation of Non-Steriodal Anti-Inflammatory Drug (NSAID) induced Gastrointestinal, Renal and Cardiac complications

ASSESSMENT OF NON-STEROIDAL ANTI-INFLAMMATORY DRUG (NSAID) INDUCED GASTROINTESTINAL, RENAL AND CARDIAC COMPLICATIONS: A MULTICENTRIC CROSS SECTIONAL OBSERVATIONAL STUDY.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2014/05/004609
Enrollment
3600
Registered
2014-05-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients attending the OPD or hospitalized will be screened.

Interventions

Intervention1: Not applicable: Not applicable

Sponsors

Wockhardt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: OPD/indoor adult patients who have been advised or have undergone upper GI endoscopy (for gastrointestinal patients)/ any one or more of the following investigations: ECG, TMT, echocardiography (for cardiac patients)/ any one or more of the following investigations: serum urea, creatinine, creatinine clearance (for renal patients)

Exclusion criteria

Exclusion criteria: Patients having gastric complications above 4 weeks/cardiac complications above 3 months /renal complications above 6 months will be not be considered eligible

Design outcomes

Primary

MeasureTime frame
To assess the prevalence of Gastrointestinal, Renal and Cardiac complications associated with NSAID use in patients.Timepoint: Visit 1—

Secondary

MeasureTime frame
To study the association between risk factors and Gastrointestinal, Renal and Cardiac complications.Timepoint: Visit 1—

Countries

India

Contacts

Public ContactDr Amey Mane

Wockhardt Ltd.

amane@wockhardt.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026